Can you believe Pro Medicus is now worth more than Bank of Queensland, Domino's Pizza?

Are any of these businesses worth buying?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Pro Medicus Limited (ASX: PME) share price has rocketed around 36x over the past 5 years from 96 cents to $35.90 today to give it a market value around $3.73 billion based on 103.98 million shares on issue.

That's more than household names like Domino's Pizza Enterprises Ltd (ASX: DM) that has a market cap of $3.65 billion, or Bank of Queensland Ltd (ASX: BOQ) that has a market value of $3.7 billion. 

Let's take a quick look at some key operating metrics for the three companies below to see how they compare to each other.

Bank of Queensland

FY 2018 (calendar year) profit and growth: $372 million, -2%

FY 2018 sales and growth: $1,110 million, +2%

Trailing price to earnings ratio: 11.2x

Company quality: A regional lender with a return on equity of 9.9% and a net interest margin of 1.98% that shows the stiff competitive environment it operates. Other macro factors counting against it include the slowing housing market and local economy. 

Domino's Pizza

FY 2019 underlying profit and growth: $141.2m, +6.1%

FY 2019 sales and growth: $2.9b, +11.9%

Trailing Price to earnings ratio: 31.2x

Company quality: Generally considered a well run business even if it has made a recent habit of missing ambitious profit forecasts. Net debt stands at a loft $514 million which is something I'm not keen on, although in compensation the "adjusted" return on equity is a lofty 44.9% for FY 2019. 

Pro Medicus 

FY 2018 profit and growth: $19.1m, +92%

FY 2018 sales and growth: $50.1m, +48%

Trailing price to earnings ratio: 163x

Company quality: Generally considered a high-quality business operating on very high profit margins that suggest its economics, moat and product quality are strong. It's also regarded as having a strong outlook backed up by the large US and global market opportunity ahead. No debt and a return on equity of 39% are the cherry on top.

Foolish takeaway 

I must admit this is a rather crude analysis, but it should show to less experienced investors why the market values different businesses in different ways.

Generally if any company like Pro Medicus can nearly double its profits over a number of years it's likely to be very highly-prized by investors. 

While a business like BOQ is rated far cheaper, but on a price to earnings ratio of 9.9x you'd only have to wait 9.9 years to get your money back in earnings for every $1 invested assuming profits stay flat.

If they grow even just a little but consistently over the long term you're likely to make handsome returns at a much better risk adjusted rate than Pro Medicus. And just compare the current net profits between the two. 

Domino's is the business in the middle of the two that still trades on a relatively high PE, but has a track record of very strong profit growth. 

Tom Richardson owns shares of Pro Medicus Ltd.

You can find Tom on Twitter @tommyr345

The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended Domino's Pizza Enterprises Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man in a business suit scratches his head looking at a graph that started high then dips, then starts to go up again like a rollercoaster.
Healthcare Shares

Is Sigma Healthcare share a healthy buy, after hitting new lows?

The Chemist Warehouse merger and ageing population might boost this stock's appeal.

Read more »

A male ASX 200 broker wearing a blue shirt and black tie holds one hand to his chin with the other arm crossed across his body as he watches stock prices on a digital screen while deep in thought
Share Market News

5 things to watch on the ASX 200 on Tuesday

Here's what to expect on the Australian share market today.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Share Market News

This new ASX stock has returned 70% since January

This new stock might get a lot of attention...

Read more »

A female CSL investor looking happy holds a big fan of Australian cash notes in her hand representing strong dividends being paid to her
Opinions

2 strong Australian stocks to buy now with $10,000

These businesses have a strong outlook for long-term growth.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Buy, hold, sell: Catapult, Step One, WiseTech Global shares

Morgans has given its verdict on these shares. Are they buys, holds, or sells?

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »